6046 Federal Register / Vol. 70, No. 23 / Friday, February 4, 2005 / Notices 

of the General Counsel, U.S. Nuclear 

Regulatory Commission, Washington DC 

20555; the Secretary, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555; and the Executive Secretary, 

U.S. Department of State, Washington, 

DC 20520. 

In its review of the application for a 

license to export special nuclear 

material as defined in 10 CFR Part 110 

and noticed herein, the Commission 

does not evaluate the health, safety or 

environmental effects in the recipient 

nation of the material to be exported. 

The information concerning the 

application follows.

NRC EXPORT LICENSE APPLICATION FOR HIGH-ENRICHED URANIUM

Name of applicant

Date of application

Date received

Application number

Docket number 

Material type End use Country of 

destination 

DOE/NNSA—Y12 .....................................

September 7, 2004 

September 24, 2004 

XSNM03369 

11005512

High-Enriched Uranium ........................... To fabricate targets for irradiation in the 

National Research Universal (NRU) 

Reactor to produce medical isotopes 

Canada. 

For the Nuclear Regulatory Commission.

Dated this 24 day of January, 2005, at 

Rockville, Maryland. 

Margaret M. Doane, 

Deputy Director, Office of International 

Programs.

[FR Doc. 05–2134 Filed 2–3–05; 8:45 am] 

BILLING CODE 7590–01–M

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 030–33635, License No.45–

15200–04, EA–04–103] 

In the Matter of Soil Consultants, Inc., 

ATTN: Mr. Joseph W. Dixon, President, 

9303 Center Street, Manassas, VA 

20110–5547; Order Imposing Civil 

Monetary Penalty 

I 

Soil Consultants, Inc. (Licensee) is the 

holder of Materials License No. 45–

15200–04 issued by the Nuclear 

Regulatory Commission (NRC or 

Commission) on October 6, 2004, 

Amendment No. 03. The license 

authorizes the Licensee to use sealed 

source(s) contained in portable gauging 

devices (registered pursuant to 10 CFR 

32.320 or equivalent Agreement State 

regulation) for measuring properties of 

materials in accordance with the 

conditions specified therein. 

II 

An investigation of the Licensee’s 

activities was completed on February 

11, 2004. The results of this 

investigation and the NRC’s further 

consideration of this matter, including a 

predecisional enforcement conference 

held with you on August 12, 2004, 

indicated that the Licensee had not 

conducted its activities in full 

compliance with NRC requirements. A 

written Notice of Violation and 

Proposed Imposition of Civil Penalty 

(Notice) was served upon the Licensee 

by letter dated October 6, 2004. The 

Notice states the nature of violation, the 

provision of the NRC’s requirements 

that the Licensee had violated, and the 

amount of the civil penalty proposed for 

the violation. 

The licensee responded to the Notice 

in letters dated November 5, 2004, and 

December 2, 2004. In its response, the 

Licensee denied a violation occurred. 

III 

After consideration of the Licensee’s 

response and the statements of fact, 

explanation, and argument for 

mitigation contained therein, the NRC 

staff has determined, as set forth in the 

Appendix to this Order, that the 

violation occurred as stated and that the 

penalty proposed for the violation 

designated in the Notice should be 

imposed. 

IV 

In view of the foregoing and pursuant 

to Section 234 of the Atomic Energy Act 

of 1954, as amended (Act), 42 U.S.C. 

2282 and 10 CFR 2.205, it is herby 

ordered that:

The Licensee pay a civil penalty in 

the amount of $9,600 within 30 days of 

the date of this Order, in accordance 

with NUREG/BR–0254. In addition, at 

the time of making payment, the 

licensee shall submit a statement 

indicating when, and by what method, 

payment was made, to the Director, 

Office of Enforcement, U.S. Nuclear 

Regulatory Commission, One White 

Flint North, 11555 Rockville Pike, 

Rockville, MD 20852–2738. 

V 

The Licensee may request a hearing 

within 30 days of the date of this Order. 

Where good cause is shown, such as 

requesting to engage in alternative 

dispute resolution, consideration will be 

given to extending the time to request a 

hearing. A request for extension of time 

must be made in writing to the Director, 

Office of Enforcement, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555, and include a statement of 

good cause for the extension. A request 

for a hearing should be clearly marked 

as a ‘‘Request for an Enforcement 

Hearing’’ and shall be submitted to the 

Secretary, U.S. Nuclear Regulatory 

Commission, ATTN: Rulemaking and 

Adjudications Staff, Washington, DC 

20555. Copies also shall be sent to the 

Director, Office of Enforcement, U.S. 

Nuclear Regulatory Commission, 

Washington, DC 20555, to the Assistant 

General Counsel for Materials Litigation 

and Enforcement at the same address, 

and to the Regional Administrator, NRC 

Region I, 475 Allendale Road, King of 

Prussia, PA 19406–1415. Because of 

continuing disruption in delivery of 

mail to United States Government 

offices, it is requested that requests for 

hearings be transmitted to the Secretary 

of the Commission either by means of 

facsimile transmission to 301–415–1101 

or by e-mail to hearingdocket@nrc.gov

and also to the Office of the General 

Counsel either by means of facsimile 

transmission to 301–415–3725 or by email to OGCMailCenter@nrc.gov. 

If a hearing is requested, the 

Commission will issue an Order 

designating the time and place of the 

hearing. If the Licensee fails to request 

a hearing within 30 days of the date of 

this Order (or if written approval of an 

extension of time in which to request a 

hearing has not been granted), the 

provisions of this Order shall be 

effective without further proceedings. If 

payment has not been made by that 

time, the matter may be referred to the 

Attorney General for collection. 

Federal Register / Vol. 70, No. 23 / Friday, February 4, 2005 / Notices 6047

In the event that the Licensee requests 

a hearing as provided above, the issues 

to be considered at such hearing shall 

be: 

(a) Whether the Licensee was in 

violation of the Commission’s 

requirements as set forth in the Notice 

referred to in Section II above, and 

(b) Whether, on the basis of such 

violation, this Order should be 

sustained.

Dated this 27th day of January 2005.

For the Nuclear Regulatory Commission. 

Frank J. Congel, 

Director, Office of Enforcement.

[FR Doc. 05–2136 Filed 2–3–05; 8:45 am] 

BILLING CODE 7590–01–P

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 030–20885] 

Notice of Availability of Environmental 

Assessment and Finding of No 

Significant Impact for License 

Amendment for Genzyme Biosurgery’s 

Facility in Ridgefield, NJ

AGENCY: Nuclear Regulatory 

Commission.

ACTION: Notice of availability.

FOR FURTHER INFORMATION CONTACT:

Kathy Dolce Modes, Materials Security 

& Industrial Branch, Division of Nuclear 

Materials Safety, Region I, 475 

Allendale Road, King of Prussia, 

Pennsylvania 19406, telephone (610) 

337–5251, fax (610) 337–5269; or by email: KAD@NRC.GOV.

SUPPLEMENTARY INFORMATION: 

I. Introduction 

The Nuclear Regulatory Commission 

(NRC) is issuing a license amendment to 

Genzyme Biosurgery for Materials 

License No. 29–23308–01, to authorize 

release of its facility in Ridgefield, New 

Jersey for unrestricted use. NRC has 

prepared an Environmental Assessment 

(EA) in support of this action in 

accordance with the requirements of 10 

CFR part 51. Based on the EA, the NRC 

has concluded that a Finding of No 

Significant Impact (FONSI) is 

appropriate. The amendment will be 

issued following the publication of this 

notice. 

II. EA Summary 

The purpose of the action is to 

authorize the release of the licensee’s 

Ridgefield, New Jersey facility for 

unrestricted use. Genzyme Biosurgery 

was authorized by NRC from December 

23, 1983, to use radioactive materials for 

research and development purposes at 

the site. On June 4, 2004, Genzyme 

Biosurgery requested that NRC release 

the facility for unrestricted use. 

Genzyme Biosurgery has conducted 

surveys of the facility and provided 

information to the NRC to demonstrate 

that the site meets the license 

termination criteria in subpart E of 10 

CFR part 20 for unrestricted use. 

The NRC staff has prepared an EA in 

support of the license amendment. The 

facility was remediated and surveyed 

prior to the licensee requesting the 

license amendment. The NRC staff has 

reviewed the information and final 

status survey submitted by Genzyme 

Biosurgery. Based on its review, the staff 

has determined that there are no 

additional remediation activities 

necessary to complete the proposed 

action. Therefore, the staff considered 

the impact of the residual radioactivity 

at the facility and concluded that since 

the residual radioactivity meets the 

requirements in subpart E of 10 CFR 

part 20, a Finding of No Significant 

Impact is appropriate. 

III. Finding of No Significant Impact 

The staff has prepared the EA 

(summarized above) in support of the 

license amendment to terminate the 

license and release the facility for 

unrestricted use. The NRC staff has 

evaluated Genzyme Biosurgery’s request 

and the results of the surveys and has 

concluded that the completed action 

complies with the criteria in subpart E 

of 10 CFR part 20. The staff has found 

that the environmental impacts from the 

action are bounded by the impacts 

evaluated by NUREG–1496, Volumes 1–

3, ‘‘Generic Environmental Impact 

Statement in Support of Rulemaking on 

Radiological Criteria for License 

Termination of NRC-Licensed 

Facilities’’ (ML042310492, 

ML042320379, and ML042330385). On 

the basis of the EA, the NRC has 

concluded that the environmental 

impacts from the action are expected to 

be insignificant and has determined not 

to prepare an environmental impact 

statement for the action. 

IV. Further Information 

Documents related to this action, 

including the application for the license 

amendment and supporting 

documentation, are available 

electronically at the NRC’s Electronic 

Reading Room at http://www.nrc.gov/

reading-rm/adams.html. From this site, 

you can access the NRC’s Agencywide 

Document Access and Management 

System (ADAMS), which provides text 

and image files of NRC’s public 

documents. The ADAMS accession 

numbers for the documents related to 

this notice are: Environmental 

Assessment (ADAMS Accession No. 

ML050270048), ‘‘Report of the 

Decommissioning of the Genzyme 

Biosurgery Research and Development 

Laboratories for the Purpose of 

Surrendering the Company’s 

Radioactive Materials License’’ included 

with the licensee’s letter dated June 4, 

2004 (ADAMS Accession No. 

ML041800154) and additional 

information dated October 15, 2004 

(ADAMS Accession No. ML042990427). 

Please note that on October 25, 2004, 

the NRC terminated public access to 

ADAMS and initiated an additional 

security review of publicly available 

documents to ensure that potentially 

sensitive information is removed from 

the ADAMS database accessible through 

the NRC’s Web site. Interested members 

of the public may obtain copies of the 

referenced documents for review and/or 

copying by contacting the Public 

Document Room pending resumption of 

public access to ADAMS. The NRC 

Public Documents Room is located at 

NRC Headquarters in Rockville, MD, 

and can be contacted at (800) 397–4209, 

(301) 415–4737 or by e-mail to 

pdr@nrc.gov.

Dated in King of Prussia, Pennsylvania this 

27th day of January, 2005.

For the Nuclear Regulatory Commission. 

James P. Dwyer, 

Chief, Commercial and R&D Branch, Division 

of Nuclear Materials Safety, Region I.

[FR Doc. 05–2138 Filed 2–3–05; 8:45 am] 

BILLING CODE 7590–01–P

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 70–3098] 

Duke Cogema Stone and Webster’s 

Proposed Mixed Oxide Fuel 

Fabrication Facility; Notice of 

Availability of Final Environmental 

Impact Statement

AGENCY: Nuclear Regulatory 

Commission.

ACTION: Notice of availability of final 

environmental impact statement. 

FOR FURTHER INFORMATION CONTACT:

Matthew Blevins, Senior Project 

Manager, Environmental and 

Performance Assessment Directorate, 

Division of Waste Management and 

Environmental Protection, Office of 

Nuclear Material Safety and Safeguards, 

U.S. Nuclear Regulatory Commission, 

Washington, DC 20555. Telephone: 

(301) 415–7684; e-mail: mxb6@nrc.gov.

SUMMARY: Notice is hereby given that 

the U.S. Nuclear Regulatory